| Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study C Eriksson, J Sun, M Bryder, G Bröms, ÅH Everhov, A Forss, T Jernberg, ... Alimentary Pharmacology & Therapeutics 59 (9), 1122-1133, 2024 | | 2024 |
| Histologic Remission in Inflammatory Bowel Disease and Female Fertility: A Nationwide Study K Mårild, J Söderling, O Stephansson, J Axelrad, J Halfvarson, G Bröms, ... Gastroenterology 166 (5), 802-814. e18, 2024 | | 2024 |
| Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide cohort study 2003-2021 C Eriksson, J Sun, M Bryder, G Broms, AH Everhov, A Forss, T Jernberg, ... JOURNAL OF CROHNS & COLITIS 18, I1955-I1956, 2024 | | 2024 |
| P1095 Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide cohort study 2003-2021 C Eriksson, J Sun, M Bryder, G Bröms, ÅH Everhov, A Forss, T Jernberg, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1967-i1968, 2024 | | 2024 |
| P1089 Disease characteristics at time of diagnosis of adult onset inflammatory bowel disease and the risk of venous thromboembolism in the modern era–A Swedish nationwide … G Bröms, A Forss, J Eriksson, M Linder, C Eriksson, J Askling, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1956-i1958, 2024 | | 2024 |
| Inflammatory bowel disease is not linked to a higher rate of adverse events in colonoscopy—a nationwide population-based study in Sweden BT Alexandersson, A Andreasson, C Hedin, G Broms, PT Schmidt, ... Journal of Crohn's and Colitis 17 (12), 1962-1967, 2023 | | 2023 |
| Increasing healthcare costs in inflammatory bowel disease 2007–2020 in Sweden ÅH Everhov, J Söderling, G Befrits, H Khalili, G Bröms, M Neovius, ... Alimentary pharmacology & therapeutics 58 (7), 692-703, 2023 | 7 | 2023 |
| Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease C Eriksson, J Söderling, S Karlqvist, G Bröms, ÅH Everhov, D Bergemalm, ... Digestive Diseases and Sciences 68 (7), 3119-3128, 2023 | 3 | 2023 |
| Atomoxetine in early pregnancy and the prevalence of major congenital malformations: A multinational study G Bröms, S Hernandez-Diaz, KF Huybrechts, BT Bateman, EB Kristiansen, ... The Journal of Clinical Psychiatry 84 (1), 45077, 2023 | 1 | 2023 |
| Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study K Mårild, J Söderling, O Stephansson, J Axelrad, J Halfvarson, G Bröms, ... EClinicalMedicine 53, 2022 | 3 | 2022 |
| Association between folic acid use during pregnancy and gestational diabetes mellitus: Two population-based Nordic cohort studies L Pazzagli, S Segovia Chacón, C Karampelias, JM Cohen, G Bröms, ... Plos one 17 (8), e0272046, 2022 | 2 | 2022 |
| IBD in the postpartum period: spotlight on maternal outcomes G Bröms Inflammatory Bowel Diseases 28 (6), 980-981, 2022 | 2 | 2022 |
| Identification of childhood-onset inflammatory bowel disease in Swedish healthcare registers: a validation study N Mouratidou, P Malmborg, J Järås, V Sigurdsson, O Sandström, ... Clinical epidemiology, 591-600, 2022 | 26 | 2022 |
| The patterns of use of medications for inflammatory bowel disease during pregnancy in the US and Sweden are changing G Bröms, S Friedman, SC Kim, ME Wood, S Hernandez-Diaz, G Brill, ... Inflammatory Bowel Diseases 27 (9), 1427-1434, 2021 | 10 | 2021 |
| Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study G Bröms, J Söderling, MC Sachs, J Halfvarson, SWIBREG Study Group, ... Scandinavian Journal of Gastroenterology 56 (4), 410-421, 2021 | 13 | 2021 |
| Psychoeducation and motivational interviewing to reduce relapses and increase patients’ involvement in antipsychotic treatment: interventional study G Bröms, L Cahling, A Berntsson, L Öhrmalm BJPsych Bulletin 44 (6), 265-268, 2020 | 6 | 2020 |
| Paediatric infections in the first 3 years of life after maternal anti‐TNF treatment during pregnancy G Bröms, H Kieler, A Ekbom, M Gissler, K Hellgren, MK Leinonen, ... Alimentary Pharmacology & Therapeutics 52 (5), 843-854, 2020 | 30 | 2020 |
| Antipsychotic drug use in pregnancy: a multinational study from ten countries J Reutfors, CE Cesta, JM Cohen, BT Bateman, R Brauer, K Einarsdóttir, ... Schizophrenia research 220, 106-115, 2020 | 51 | 2020 |
| Anti‐TNF treatment during pregnancy and birth outcomes: a population‐based study from Denmark, Finland, and Sweden G Bröms, H Kieler, A Ekbom, M Gissler, K Hellgren, ... Pharmacoepidemiology and Drug Safety 29 (3), 316-327, 2020 | 62 | 2020 |
| Antidiabetic medication use during pregnancy: an international utilization study CE Cesta, JM Cohen, L Pazzagli, BT Bateman, G Bröms, K Einarsdóttir, ... BMJ Open Diabetes Research and Care 7 (1), e000759, 2019 | 54 | 2019 |
